U โ€” Science & TechnologyEIN: 863225994ยท Ruling Year: 2022

Nucleate Bio Inc

Brighton, Massachusetts

B+Health Score
69B+

Financial Health Score

9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.

Good

๐Ÿ’ฐ
$2.6M
Total Revenue
๐Ÿ“Š
$2.4M
Total Expenses
๐Ÿฆ
$514K
Net Assets
๐Ÿ“‹
$229K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+114.6%
Year-over-year change (2022 โ†’ 2023)
Net Margin
+7.6%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.22
Net assets divided by total expenses
Liabilities-to-Assets
30.8%
Total liabilities as % of total assets

Filing History

3 filings on record
YearRevenueExpensesAssets
2023$2,574,023โ†‘115%$2,379,621โ†‘142%$743,650โ†‘13%
2022$1,199,698โ†‘812%$982,814โ†‘3351%$659,215โ†‘159%
2021$131,502$28,481$254,780

Frequently Asked Questions

What does Nucleate Bio Inc do?โ–ผ

Nucleate Bio Inc is a science & technology nonprofit organization based in Massachusetts. It is classified under NTEE code U50 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Nucleate Bio Inc financially healthy?โ–ผ

Based on our 9-metric Financial Health Score model, Nucleate Bio Inc has a score of 69/100 (Grade: B+). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.

How much revenue does Nucleate Bio Inc generate?โ–ผ

Nucleate Bio Inc reports $2.4M in annual revenue and holds $1.0M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Science & Technology category, or browse all nonprofits in Massachusetts.

Nucleate Bio Inc โ€” Brighton, MA | GiveScope